Nadolol
Sponsors
Rigshospitalet, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Taipei Veterans General Hospital, Taiwan, Invion, Inc., National Science and Technology Council, Taiwan
Conditions
AsthmaCirrhosisGastric Variceal BleedingGastrointestinal HemorrhageIVF)Infantile HemangiomaLiver Cirrhosis and Hepatoma.Mild Persistent Asthma, Uncomplicated
Phase 1
Phase 2
Nadolol for Proliferating Infantile Hemangiomas
CompletedNCT01010308
Start: 2009-11-30End: 2012-02-29Updated: 2021-08-19
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
NCT01804218
Start: 2013-03-31Target: 60Updated: 2016-08-09
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
CompletedNCT01825122
Start: 2014-03-31End: 2015-08-31Updated: 2017-02-01
Phase 3
Phase 4
Secondary Prophylaxis After Variceal Bleeding in Non-Responders
CompletedNCT00450164
Start: 2000-11-30End: 2004-06-30Target: 50Updated: 2007-03-21
Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
NCT00567216
Start: 2007-04-30End: 2010-07-31Target: 120Updated: 2010-06-08
A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
CompletedNCT00921349
Start: 2004-12-31End: 2009-05-31Updated: 2009-06-16
The RIME-IVF study - Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricular Fibrillation patients
RecruitingCTIS2024-518057-41-00
Start: 2019-02-22Target: 218Updated: 2024-10-23